The Addition of C-Reactive Protein to Validated Staging Systems Improves Their Prognostic Ability in Patients with Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|86|5-6|308-317

ISSN： 0030-2414

Source： Oncology, Vol.86, Iss.5-6, 2014-06, pp. : 308-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Impact of Intratumoral C-Reactive Protein Expression in Patients with Clear Cell Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 92, Iss. 3, 2013-12 ,pp. : 270-275

Karger

Access to resources Recommend Favorite

Prognostic value of C‐reactive protein levels in patients with cirrhosis

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 753-760

John Wiley & Sons Inc

Access to resources Recommend Favorite

C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 5, 2016-04 ,pp. : 266-271

Karger

Access to resources Recommend Favorite

Slight elevation of high‐sensitivity C‐reactive protein to predict recurrence and survival in patients with early stage hepatitis C‐related hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 6, 2015-06 ,pp. : 645-655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preoperative C-Reactive Protein in the Serum: A Prognostic Biomarker for Upper Urinary Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy

By  

Urologia Internationalis, Vol. 93, Iss. 3, 2014-08 ,pp. : 352-360

Karger

Access to resources Recommend Favorite